LUCENTIX
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme called luciferase, is engineered to change the color of the emitted light in response to changes in analyte concentration. In absence of the analyte the molecular system emits red light, while at high analyte concentration the light is blue. Lucentix is headquartered in Lausanne, Switzerland.
LUCENTIX
Industry:
Biotechnology Medical Device Sensor
Founded:
2015-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.lucentix.ch
Status:
Active
Email Addresses:
[email protected]
Total Funding:
130 K CHF
Technology used in webpage:
SPF Zoho Mail Key Systems DNS Key-Systems
Similar Organizations
Merck Accelerator
Merck Accelerator program supports startups in the fields of healthcare, life science, performance materials and additional search fields.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Founder
Investors List
Venture Kick
Venture Kick investment in Pre Seed Round - Lucentix
Venture Kick
Venture Kick investment in Grant - Lucentix
Venture Kick
Venture Kick investment in Grant - Lucentix
Official Site Inspections
http://www.lucentix.ch
- Host name: 104.247.82.51
- IP address: 104.247.82.51
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Lucentix"
Lucentix - Crunchbase Company Profile & Funding
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving …See details»
Lucentix Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Lucentix. Use the PitchBook Platform to explore the full profile.See details»
Lucentix SA - VentureRadar
Website: http://www.lucentix.ch. Develops biosensor technology by utilizing research from PhD studies at École Polytechnique Fédérale de Lausanne, aiming to advance diagnostics. …See details»
Lucentix SA - Venture Kick
ORGANIZATION. Transforming scientific innovation into commercial activity and jobs is the foundation of social and economic prosperity. Early-stage startups bear high risks that aren’t …See details»
Lucentix SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore Lucentix SA with its drug pipeline, therapeutic area, technology platform, .See details»
Lucentix SA - Lausanne, Switzerland - bionity.com
News. We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.See details»
Lucentix - Company Profile - Tracxn
Nov 15, 2024 · Lucentix - Developer of sensors for home-based blood testing. This company is not active anymore. Raised a total funding of $131K over 1 round from 2 investors. Founded …See details»
Lucentix - Crunchbase
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva.See details»
Lucentix - Funding, Financials, Valuation & Investors - Crunchbase
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva.See details»
Lucentix - Products, Competitors, Financials, Employees, …
Lucentix develops biosensor technology. Use the CB Insights Platform to explore Lucentix's full profile.See details»
When a single drop of blood brings Swiss innovation forward
Jul 16, 2015 · The EPFL Spin-off Lucentix develops a new biosensor technology that allows patients to measure the precise concentration of substances in a single drop of blood or saliva …See details»
Antibody biosensor offers unlimited point-of-care drug monitoring
May 16, 2017 · EPFL scientists, working through their startup LUCENTIX, have now developed an antibody-linked biosensor that can track drug concentration in the blood by changing its color. …See details»
La lumière des lucioles révolutionne les diagnostics médicaux
Jul 23, 2015 · Des scientifiques de l’EPFL ont mis à profit la lumière émise par les lucioles pour détecter des molécules biologiques sans recourir à des systèmes onéreux et complexes. La …See details»
Ranibizumab - Wikipedia
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.See details»
Lucentis - European Medicines Agency (EMA)
Lucentis is a medicine used to treat adults with certain sight problems caused by damage to the retina (the light-sensing layer at the back of the eye), and more specifically its central region, …See details»
Lucentix SA | VentureRadar
Website: http://www.lucentix.ch. Develops biosensor technology by utilizing research from PhD studies at École Polytechnique Fédérale de Lausanne, aiming to advance diagnostics. …See details»
LUCENTIS® (ranibizumab) for wAMD, DR & DME, mCNV, & RVO
Learn more about LUCENTIS’ strength in vision and support across 5 retinal indications below. CONTRAINDICATIONS. LUCENTIS is contraindicated in patients with ocular or periocular …See details»
Quanterix Announces First Collaborations with Five Health …
Feb 26, 2024 · Committed to transforming the landscape of Alzheimer’s Disease (AD) diagnostic testing, Lucent Diagnostics, a Quanterix brand, is revolutionizing AD patient care by providing …See details»
compendium.ch
Lucentis ist indiziert bei Frühgeborenen für die Behandlung der Frühgeborenen Retinopathie (RPM): RPM in Zone I (Krankheitsstadium 1+, 2+, 3 oder 3+), Zone II (Krankheitsstadium 3+) …See details»
compendium.ch
Oct 16, 2024 · Lucentis ist indiziert bei Erwachsenen für die Behandlung: der exsudativen (feuchten) altersbezogenen Makuladegeneration (feuchte AMD). eines Visusverlustes durch …See details»